Home › Compare › CMRAW vs PLD

CMRAW vs PLD: Dividend Comparison 2026

CMRAW yields 10362.69% · PLD yields 3.18%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CMRAW wins by $78335784849600944.00M in total portfolio value
10 years
CMRAW
CMRAW
● Live price
10362.69%
Share price
$0.02
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$78335784849600944.00M
Annual income
$76,876,438,600,915,240,000,000.00
Full CMRAW calculator →
PLD
PLD
● Live price
3.18%
Share price
$128.78
Annual div
$4.10
5Y div CAGR
74.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$6.50M
Annual income
$5,256,436.18
Full PLD calculator →

Portfolio growth — CMRAW vs PLD

📍 CMRAW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCMRAWPLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CMRAW + PLD cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
CMRAW pays
PLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CMRAW
Annual income on $10K today (after 15% tax)
$880,829.02/yr
After 10yr DRIP, annual income (after tax)
$65,344,972,810,777,950,000,000.00/yr
PLD
Annual income on $10K today (after 15% tax)
$270.62/yr
After 10yr DRIP, annual income (after tax)
$4,467,970.75/yr
At 15% tax rate, CMRAW beats the other by $65,344,972,810,777,940,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CMRAW + PLD for your $10,000?

CMRAW: 50%PLD: 50%
100% PLD50/50100% CMRAW
Portfolio after 10yr
$39167892424800472.00M
Annual income
$38,438,219,300,457,620,000,000.00/yr
Blended yield
98.14%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

CMRAW
No analyst data
Altman Z
-28.1
Piotroski
2/9
PLD
Analyst Ratings
25
Buy
16
Hold
1
Sell
Consensus: Buy
Price Target
$136.00
+5.6% upside vs current
Range: $119.00 — $155.00
Altman Z
1.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CMRAW buys
0
PLD buys
0
No recent congressional trades found for CMRAW or PLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCMRAWPLD
Forward yield10362.69% ✓3.18%
Annual dividend / share$2.00$4.10 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%74.4% ✓
Portfolio after 10y$78335784849600944.00M ✓$6.50M
Annual income after 10y$76,876,438,600,915,240,000,000.00 ✓$5,256,436.18
Total dividends collected$78238734181699024.00M ✓$6.37M
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: CMRAW vs PLD ($10,000, DRIP)

YearCMRAW PortfolioCMRAW Income/yrPLD PortfolioPLD Income/yrGap
1← crossover$1,046,969$1,036,269.43$11,255$555.24+$1.04M → CMRAW
2$102,516,745$101,396,487.34$13,062$1,018.59+$102.50M → CMRAW
3$9,388,666,498$9,278,973,581.18$15,903$1,926.67+$9388.65M → CMRAW
4$804,237,430,573$794,191,557,419.90$20,839$3,823.32+$804237.41M → CMRAW
5$64,440,729,401,315$63,580,195,350,601.93$30,464$8,166.08+$64440729.37M → CMRAW
6$4,830,127,690,198,710$4,761,176,109,739,303.00$52,054$19,457.30+$4830127690.15M → CMRAW
7$338,693,420,711,903,550$333,525,184,083,391,000.00$109,886$54,188.93+$338693420711.79M → CMRAW
8$22,219,525,310,042,270,000$21,857,123,349,880,533,000.00$304,030$186,451.18+$22219525310041.97M → CMRAW
9$1,363,874,998,771,683,700,000$1,340,100,106,689,938,500,000.00$1,166,125$840,813.32+$1363874998771682.75M → CMRAW
10$78,335,784,849,600,940,000,000$76,876,438,600,915,240,000,000.00$6,504,190$5,256,436.18+$78335784849600944.00M → CMRAW

CMRAW vs PLD: Complete Analysis 2026

CMRAW — Stock

Comera Life Sciences Holdings, Inc., a preclinical stage life sciences company, develops an internal portfolio of proprietary therapeutics that incorporate its proprietary formulation platform, SQore. Its SQore platform is designed to enable the conversion of intravenous (IV) biologics to subcutaneous (SQ) versions. The company is advancing its primary product programs, CLS-001, a preclinical stage biobetter for Crohn's and Ulcerative Colitis disease, and CLS-002, a preclinical stage biobetter for various oncology indications. Comera Life Sciences Holdings, Inc. was founded in 2014 and is headquartered in Woburn, Massachusetts.

Full CMRAW Calculator →

PLD — REIT

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.

Full PLD Calculator →
📬

Get this CMRAW vs PLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CMRAW vs SCHDCMRAW vs JEPICMRAW vs OCMRAW vs KOCMRAW vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.